Pediatric oncology Clinical Trials
Recruiting pediatric oncology studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat pediatric oncology. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting pediatric oncology studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting pediatric oncology trials
TeamTalk: Improving Inter-professional Communication During Cancer Treatment
Food is Medicine in Survivorship: Examining the Feasibility and Impact of a Scalable Food Delivery and Culinary Medicine Program (FoodiiS) Among Pediatric Cancer Survivors and Their Families
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT
HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia
Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Combination Immunotherapy Targeting Sarcomas
Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors
Music Therapy for Oral Mucositis Pain in Pediatric Patients
B7-H3.CD28Z.CART in Solid Tumors
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
The Comparative Effectiveness Evaluation of the Impact of Digital Education
Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia
Phase I Study of FXS0683 in the Treatment of Blood Tumors
Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
Telerehabilitation-Based Dance Therapy in Pediatric Cancer
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Video Inspired Discussions About Ethical Outcomes in Pediatrics
Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Pain Caregiver Resource (PainCaRe)
ALL Backbone in AYAs
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
Tumor-Lymph Node Mapping
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
Questionnaire on Congenital Cancer Signs Through Self-Assessment
Social and Physical Activity as Rehabilitation for Preschool Kids With Cancer
Wearable Technology-Supported Exercise Program for Fatigue and Quality of Life in Pediatric Cancer Patients (WE-EX PedsCa)
From Kitchen to Clinic
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Treatment for Ph-negative ALL for Adults up to 65 Years
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
Pediatric oncology clinical trials — common questions
Are pediatric oncology clinical trials free to join?
Yes. Participating in a pediatric oncology clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a pediatric oncology clinical trial?
Each pediatric oncology study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a pediatric oncology trial near me?
Use the location controls above. We'll show recruiting pediatric oncology trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many pediatric oncology trials are recruiting right now?
We're currently tracking roughly 218 recruiting pediatric oncology trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.